Thermo Fisher Scientific Influenza A H3N2 HA (A/Brisbane/10/2007) Recombinant Rabbit Monoclonal Antibody (006)

Applications

• ELISA (ELISA): 1:5,000–1:10,000

Product Specifications

Product Specific Information

This product is preservative-free. It is recommended to add sodium azide to avoid contamination (final concentration 0.05%–0.1%).

Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning the specific antibody DNA sequences from immunoreactive rabbits, followed by screening of individual clones to select optimal candidates for production.

Advantages of recombinant rabbit monoclonal antibodies:

• Improved specificity and sensitivity
• Lot-to-lot consistency
• Animal origin-free formulation
• Broader immunoreactivity due to the rabbit immune repertoire

This antibody has specificity for Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA.

Target Information

Influenza viruses consist of three types (A, B, and C), which make up three of the five genera in the Orthomyxoviridae family. Commonly known as the flu, influenza strains can infect both birds and mammals. The virus forms roughly spherical particles with a viral envelope containing two major glycoproteins (hemagglutinin and neuraminidase) surrounding the central RNA genome and associated proteins.

Unlike many viruses, the influenza genome is segmented into seven to eight fragments of negative-sense RNA, each encoding different viral proteins. Influenza spreads seasonally, causing approximately 3–5 million severe cases and 250,000–500,000 deaths annually, with higher numbers during pandemics.

For Research Use Only.
Not for use in diagnostic procedures. Not for resale without express authorization.